- Home
- ALLK vs AUST Comparison
ALLK vs AUST Comparison
Compare ALLK & AUST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLK
- AUST
- Stock Information
- Founded
- ALLK 2012
- AUST 2020
- Country
- ALLK United States
- AUST Canada
- Employees
- ALLK N/A
- AUST N/A
- Industry
- ALLK Biotechnology: Pharmaceutical Preparations
- AUST
- Sector
- ALLK Health Care
- AUST
- Exchange
- ALLK Nasdaq
- AUST Nasdaq
- Market Cap
- ALLK 23.0M
- AUST 21.5M
- IPO Year
- ALLK 2018
- AUST 2022
- Fundamental
- Price
- ALLK $0.32
- AUST $1.30
- Analyst Decision
- ALLK Hold
- AUST
- Analyst Count
- ALLK 3
- AUST 0
- Target Price
- ALLK $2.00
- AUST N/A
- AVG Volume (30 Days)
- ALLK 1.8M
- AUST 121.8K
- Earning Date
- ALLK 03-12-2025
- AUST 05-07-2025
- Dividend Yield
- ALLK N/A
- AUST N/A
- EPS Growth
- ALLK N/A
- AUST N/A
- EPS
- ALLK N/A
- AUST N/A
- Revenue
- ALLK N/A
- AUST N/A
- Revenue This Year
- ALLK N/A
- AUST N/A
- Revenue Next Year
- ALLK N/A
- AUST N/A
- P/E Ratio
- ALLK N/A
- AUST N/A
- Revenue Growth
- ALLK N/A
- AUST N/A
- 52 Week Low
- ALLK $0.22
- AUST $0.79
- 52 Week High
- ALLK $1.56
- AUST $3.19
- Technical
- Relative Strength Index (RSI)
- ALLK 59.90
- AUST 45.85
- Support Level
- ALLK $0.24
- AUST $1.23
- Resistance Level
- ALLK $0.27
- AUST $1.53
- Average True Range (ATR)
- ALLK 0.01
- AUST 0.16
- MACD
- ALLK 0.01
- AUST -0.02
- Stochastic Oscillator
- ALLK 96.94
- AUST 14.99
About ALLK Allakos Inc.
Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation. Its portfolio consists of antibodies that target receptors, particularly Siglec-6, Siglec-8 and other anti-Siglec antibodies, including some antibodies in preclinical development.
About AUST Austin Gold Corp.
Austin Gold Corp is a gold exploration and development company focused on gold targets and making district-scale gold discoveries in Nevada. Exploration and development of mineral projects is considered the Company's single business segment. Its projects include Kelly Creek in Humboldt County, Lone Mountain and Miller in Elko County, and Fourmile Basin in Nye County.